BIOCRYST PHARMACEUTICALS INC — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 0000882796-25-000017 | Nov 17, 2025 | Nov 13, 2025 |
| 144 | — | 0001959173-25-006976 | Nov 13, 2025 | — |
| SCHEDULE 13G | — | 0001346824-25-000052 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-048785 | Nov 4, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-006881 | Nov 3, 2025 | — |
| 425 | 425 | 0001140361-25-038088 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001140361-25-038031 | Oct 14, 2025 | — |
| 425 | 425 | 0001140361-25-038091 | Oct 14, 2025 | — |
| 425 | 425 | 0001140361-25-038032 | Oct 14, 2025 | — |
| 425 | 425 | 0001140361-25-038086 | Oct 14, 2025 | — |
| 8-K | 8-K | 0001140361-25-036875 | Oct 1, 2025 | — |
| SCHEDULE 13G | — | 0001193805-25-001316 | Sep 19, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000013 | Sep 3, 2025 | Aug 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000005 | Sep 3, 2025 | Aug 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0000882796-25-000003 | Sep 3, 2025 | Aug 29, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-020491 | Aug 15, 2025 | Aug 13, 2025 |
| 144 | — | 0001959173-25-005151 | Aug 13, 2025 | — |
| S-8 | FORM S-8 | 0001171843-25-005329 | Aug 12, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-005265 | Aug 11, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-037795 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-004977 | Aug 4, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-004869 | Jul 31, 2025 | Jul 25, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-019632 | Jul 28, 2025 | Jul 24, 2025 |
| 3 | — | 0001171843-25-004435 | Jul 11, 2025 | Jul 7, 2025 |
| 8-K | FORM 8-K | 0001171843-25-004324 | Jul 7, 2025 | — |
| 8-K | 8-K | 0001140361-25-024089 | Jun 30, 2025 | Jun 27, 2025 |
| 8-K | FORM 8-K | 0001171843-25-004186 | Jun 27, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-004091 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001171843-25-003917 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003918 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003916 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | FORM 8-K | 0001171843-25-003910 | Jun 16, 2025 | Jun 11, 2025 |
| 4 | — | 0001171843-25-003911 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003912 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003913 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003914 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | — | 0001171843-25-003915 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | FORM 8-K | 0001171843-25-003662 | Jun 4, 2025 | May 31, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-016419 | Jun 3, 2025 | May 30, 2025 |
| 4 | PRIMARY DOCUMENT | 0001127602-25-016424 | Jun 3, 2025 | May 30, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-002355 | May 15, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-003152 | May 14, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001127602-25-013478 | May 6, 2025 | May 2, 2025 |
| 10-Q | 10-Q | 0001628280-25-022658 | May 6, 2025 | Mar 31, 2025 |
| 3 | — | 0001171843-25-002822 | May 6, 2025 | May 2, 2025 |
| 8-K | FORM 8-K | 0001171843-25-002739 | May 5, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-002669 | May 1, 2025 | Apr 30, 2025 |
| DEF 14A | DEF 14A | 0001628280-25-019659 | Apr 24, 2025 | Jun 12, 2025 |
| DEFA14A | DEFA14A | 0001140361-25-015459 | Apr 24, 2025 | — |
| ARS | ARS | 0001140361-25-015469 | Apr 24, 2025 | Dec 31, 2024 |